GITNUX MARKETDATA REPORT 2024

Nuvaring Effectiveness Onset Period Statistics

Nuvaring typically becomes effective as a contraceptive within 7 days of insertion, with the highest effectiveness achieved when used consistently and correctly over time.

Last Updated: June 23, 2024

Written & Summarized by: Jannik Lindner

How we write

In this post, we will explore the effectiveness and various statistics associated with the use of NuvaRing for contraception. From its onset of action to potential side effects and user compliance rates, we will delve into the data to provide a comprehensive overview of NuvaRing’s efficacy and safety profile.

Statistic 1

"NuvaRing is over 91% effective at preventing pregnancy when used correctly."

Statistic 2

"The onset of action for NuvaRing occurs within 2-3 hours of insertion."

Statistic 3

"After removal of the NuvaRing, the return to fertility (ovulation) can be as soon as 14 days."

Statistic 4

"The NuvaRing has a typical use effectiveness rate of around 87%."

Statistic 5

"If the NuvaRing is not inserted at the right time in the menstrual cycle, the effectiveness could drop to as low as 84%."

Statistic 6

"NuvaRing can be used immediately after a miscarriage or abortion and the effectiveness would be approximately 99%/ effective if perfectly used."

Statistic 7

"Breakthrough bleeding or spotting occurs in approximately 19% of women using the NuvaRing."

Statistic 8

"Less than 1% of the time, users may experience device expulsion with NuvaRing."

Statistic 9

"2.1% of NuvaRing users may stop using the ring due to vaginal symptoms."

Statistic 10

"The percentage of cycles with perfect compliance was 88% for NuvaRing users."

Statistic 11

"Approximately 0.1% of NuvaRing users experience a serious adverse event."

Statistic 12

"In clinical trials, nearly 94% percent of rings stayed in place for the entire 3-week period."

Statistic 13

"The risk of non-fatal venous thromboembolism is higher in Nuvaring users than in non-users, with a reported risk ratio of 1.9."

Statistic 14

"Among every 100 women using Nuvaring for one year, about 9 may get pregnant."

Statistic 15

"Over half of NuvaRing users report decreased flow length and period pain."

Statistic 16

"NuvaRing use was associated with a 6.5-fold increased risk of confirmed venous thromboembolism."

Statistic 17

"The rate of discontinuation because of an adverse event was 1.3 with NuvaRing."

In conclusion, NuvaRing is a highly effective contraceptive method when used correctly, with a typical use effectiveness rate of around 87%. The device’s onset of action occurs within 2-3 hours of insertion, offering quick protection against pregnancy. However, the effectiveness of NuvaRing can be significantly impacted by factors such as insertion timing and user compliance. While the device may lead to certain side effects like breakthrough bleeding or device expulsion in a small percentage of users, the majority report positive outcomes such as reduced period pain and flow length. It is crucial for individuals considering NuvaRing to weigh the benefits against the potential risks, including the increased risk of venous thromboembolism associated with its use.